Show simple item record

dc.contributor.authorBalcioglu, Yasin Hasan
dc.contributor.authorKirlioglu, Simge Seren
dc.date.accessioned2021-03-02T17:21:24Z
dc.date.available2021-03-02T17:21:24Z
dc.date.issued2020
dc.identifier.citationBalcioglu Y. H. , Kirlioglu S. S. , "C-Reactive Protein/Albumin and Neutrophil/Albumin Ratios as Novel Inflammatory Markers in Patients with Schizophrenia", PSYCHIATRY INVESTIGATION, cilt.17, ss.902-910, 2020
dc.identifier.issn1738-3684
dc.identifier.otherav_eb3d16d0-b325-4e8f-a055-31f7eb3f4942
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/3749
dc.identifier.urihttps://doi.org/10.30773/pi.2020.0185
dc.description.abstractObjective Peripheral biomarker studies in schizophrenia are insufficient to correspond to whether inflammatory markers are trait- or state-related. The main objective of this study was to compare novel biomarkers C-reactive protein/albumin ratio (CAR), neutrophil/albtunin ratio (NAR), and complete blood count-derived inflammatory markers; neutrophilnymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), red-cell distribution width (RDW), and mean platelet volume (MPV) between patients with acutely exacerbated and remitted schizophrenia and healthy controls.
dc.language.isoeng
dc.subjectPsikiyatri
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.titleC-Reactive Protein/Albumin and Neutrophil/Albumin Ratios as Novel Inflammatory Markers in Patients with Schizophrenia
dc.typeMakale
dc.relation.journalPSYCHIATRY INVESTIGATION
dc.contributor.departmentBakirkoy Prof Mazhar Osman Training & Res Hosp Ps , ,
dc.identifier.volume17
dc.identifier.issue9
dc.identifier.startpage902
dc.identifier.endpage910
dc.contributor.firstauthorID2286449


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record